Literature DB >> 26889484

Newer therapeutics for hepatitis C.

Bhawna Poonia1, Shyam Kottilil1.   

Abstract

Year:  2016        PMID： 26889484      PMCID： PMC4731604          DOI： 10.3978/j.issn.2305-5839.2015.10.06

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  9 in total

1.  Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection.

Authors:  Shanshan He; Billy Lin; Virginia Chu; Zongyi Hu; Xin Hu; Jingbo Xiao; Amy Q Wang; Cameron J Schweitzer; Qisheng Li; Michio Imamura; Nobuhiko Hiraga; Noel Southall; Marc Ferrer; Wei Zheng; Kazuaki Chayama; Juan J Marugan; T Jake Liang
Journal:  Sci Transl Med       Date:  2015-04-08       Impact factor: 17.956

Review 2.  HCV targeting of patients with cirrhosis.

Authors:  Peter Ferenci; Karin Kozbial; Mattias Mandorfer; Harald Hofer
Journal:  J Hepatol       Date:  2015-06-19       Impact factor: 25.083

Review 3.  Treatment of hepatitis C: a systematic review.

Authors:  Anita Kohli; Ashton Shaffer; Amy Sherman; Shyam Kottilil
Journal:  JAMA       Date:  2014-08-13       Impact factor: 56.272

Review 4.  Current and future HCV therapy: do we still need other anti-HCV drugs?

Authors:  Salvatore Petta; Antonio Craxì
Journal:  Liver Int       Date:  2015-01       Impact factor: 5.828

5.  Global burden of hepatitis C: considerations for healthcare providers in the United States.

Authors:  Francisco M Averhoff; Nancy Glass; Deborah Holtzman
Journal:  Clin Infect Dis       Date:  2012-07       Impact factor: 9.079

Review 6.  Beyond interferon: rationale and prospects for newer treatment paradigms for chronic hepatitis C.

Authors:  Karoll J Cortez; Shyam Kottilil
Journal:  Ther Adv Chronic Dis       Date:  2015-01       Impact factor: 5.091

7.  Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study.

Authors:  Anita Kohli; Anuoluwapo Osinusi; Zayani Sims; Amy Nelson; Eric G Meissner; Lisa L Barrett; Dimitra Bon; Miriam M Marti; Rachel Silk; Colleen Kotb; Chloe Gross; Tim A Jolley; Sreetha Sidharthan; Tess Petersen; Kerry Townsend; D'Andrea Egerson; Rama Kapoor; Emily Spurlin; Michael Sneller; Michael Proschan; Eva Herrmann; Richard Kwan; Gebeyehu Teferi; Rohit Talwani; Gabbie Diaz; David E Kleiner; Brad J Wood; Jose Chavez; Stephen Abbott; William T Symonds; G Mani Subramanian; Phillip S Pang; John McHutchison; Michael A Polis; Anthony S Fauci; Henry Masur; Shyam Kottilil
Journal:  Lancet       Date:  2015-01-13       Impact factor: 79.321

Review 8.  Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C.

Authors:  Mark S Sulkowski; Curtis Cooper; Bela Hunyady; Jidong Jia; Pavel Ogurtsov; Markus Peck-Radosavljevic; Mitchell L Shiffman; Cihan Yurdaydin; Olav Dalgard
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03-08       Impact factor: 46.802

Review 9.  Management of Hepatitis C Post-liver Transplantation: a Comprehensive Review.

Authors:  Oscar Mitchell; Ahmet Gurakar
Journal:  J Clin Transl Hepatol       Date:  2015-06-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.